Computer-Aided Drug Discovery using SILCS technology and AI-assisted Screening of Ultralarge Compound Library
From CHARMM to SILCS: Confluence of force fields and computer aided drug design
SilcsBio Co-Founder Alex MacKerell, PhD Receives ACS Award for Computers in Chemical and Pharmaceutical Research
Dr. MacKerell to be honored at the ACS Spring 2022 National Meeting, March 20-24, in San Diego March 10, 2022, Baltimore, MD – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, announced today its Co-Founder and Chief Scientific Officer, Alexander D. MacKerell Jr., PhD, has been awarded the […]
Early Charm Launches Tech on Deck Blog to Shine Light on Future-Looking Industry Challenges & Solutions
Tech on Deck to feature fresh content by Early Charm’s expert team of scientists and entrepreneurs on unmet market needs and challenges March 7, 2022, Baltimore, MD – Early Charm, a company that creates, owns and operates ventures that convert science to revenue, today announced the launch of its Tech on Deck blog. Early Charm’s […]
Technical Sales for Drug Design Portfolio
Immediate Job Opening – 1/20/2022 Technical Sales Within Early Charm’s Drug Design Portfolio SilcsBio’s parent company, Early Charm, has a job opening to work with SilcsBio and other companies in its Drug Design Portfolio. What we do: Early Charm creates, owns, and operates businesses that convert science into revenue. We are the management […]
Invitation for a Perspective/Review Article for New Journal of Chemistry “Application of Site-Identification by Ligand Competitive Saturation in Computer-Aided Drug Design”
SilcsBio Spinout Raises $1.5 Million Investment
FOR IMMEDIATE RELEASE: SilcsBio Spinout Raises $1.5 Million to Advance Drug Development New investment from Bluedot Bio into Rasio follows initial funding from the National Foundation for Cancer Research December 2, 2021, Baltimore, MD – Rasio Therapeutics, a joint venture formed by SilcsBio and the National Foundation for Cancer Research (NFCR) to develop […]